BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 32049380)

  • 1. Investigating the associations of mucosal P2Y6 receptor expression and urinary ATP and ADP concentrations, with symptoms of overactive bladder.
    Firouzmand S; Ajori L; Towse J; Allameh F; Najafi S; Javed S; John B; Langley SEM; Fry CH; Young JS
    Neurourol Urodyn; 2020 Mar; 39(3):926-934. PubMed ID: 32049380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pilot study to investigate the associations of urinary concentrations of NO, ATP and derivatives with overactive bladder symptom severity.
    Firouzmand S; Young JS
    Exp Physiol; 2020 Jun; 105(6):932-939. PubMed ID: 32170890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of P2Y6 Receptors Facilitates Nonneuronal Adenosine Triphosphate and Acetylcholine Release from Urothelium with the Lamina Propria of Men with Bladder Outlet Obstruction.
    Silva I; Ferreirinha F; Magalhães-Cardoso MT; Silva-Ramos M; Correia-de-Sá P
    J Urol; 2015 Oct; 194(4):1146-54. PubMed ID: 26004864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered urothelial ATP signaling in a major subset of human overactive bladder patients with pyuria.
    Contreras-Sanz A; Krska L; Balachandran AA; Curtiss NL; Khasriya R; Kelley S; Strutt M; Gill HS; Taylor KM; Mansfield KJ; Wu C; Peppiatt-Wildman CM; Malone-Lee J; Duckett J; Wildman SS
    Am J Physiol Renal Physiol; 2016 Oct; 311(4):F805-F816. PubMed ID: 27358056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of P2Y6 receptors increases the voiding frequency in anaesthetized rats by releasing ATP from the bladder urothelium.
    Carneiro I; Timóteo MA; Silva I; Vieira C; Baldaia C; Ferreirinha F; Silva-Ramos M; Correia-de-Sá P
    Br J Pharmacol; 2014 Jul; 171(14):3404-19. PubMed ID: 24697602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression of brainderived neurotrophic factor in urine of patients with benign prostatic hyperplasia complicated overactive bladder symptoms].
    Hu H; Xu KX; Zhang XP; Fang ZW; Chen JW; Huo F; Wang D; Wang XF
    Beijing Da Xue Xue Bao Yi Xue Ban; 2014 Aug; 46(4):519-23. PubMed ID: 25131461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary ATP may be a dynamic biomarker of detrusor overactivity in women with overactive bladder syndrome.
    Silva-Ramos M; Silva I; Oliveira O; Ferreira S; Reis MJ; Oliveira JC; Correia-de-Sá P
    PLoS One; 2013; 8(5):e64696. PubMed ID: 23741373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between cystometric volumes, ATP release, and pH in women with overactive bladder versus controls.
    Cheng Y; Mansfield KJ; Allen W; Millard RJ; Burcher E; Moore KH
    Neurourol Urodyn; 2013 Sep; 32(7):969-73. PubMed ID: 23129360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between lower urinary tract symptoms and urinary ATP in patients with benign prostatic hyperplasia or overactive bladder.
    Sugaya K; Nishijima S; Kadekawa K; Miyazato M; Mukouyama H
    Biomed Res; 2009 Oct; 30(5):287-94. PubMed ID: 19887725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ATP released via pannexin-1 hemichannels mediates bladder overactivity triggered by urothelial P2Y6 receptors.
    Timóteo MA; Carneiro I; Silva I; Noronha-Matos JB; Ferreirinha F; Silva-Ramos M; Correia-de-Sá P
    Biochem Pharmacol; 2014 Jan; 87(2):371-9. PubMed ID: 24269631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New participant stratification and combination of urinary biomarkers and confounders could improve diagnostic accuracy for overactive bladder.
    Firouzmand S; Ajori L; Young JS
    Sci Rep; 2020 Feb; 10(1):3085. PubMed ID: 32080289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between psychological stress levels and the severity of overactive bladder symptoms.
    Lai H; Gardner V; Vetter J; Andriole GL
    BMC Urol; 2015 Mar; 15():14. PubMed ID: 25887525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic Analysis of Urothelium of Rats with Detrusor Overactivity Induced by Bladder Outlet Obstruction.
    Park EC; Lim JS; Kim SI; Lee SY; Tak YK; Choi CW; Yun S; Park J; Lee M; Chung HK; Kim KS; Na YG; Shin JH; Kim GH
    Mol Cell Proteomics; 2018 May; 17(5):948-960. PubMed ID: 29414759
    [No Abstract]   [Full Text] [Related]  

  • 14. A Comprehensive Review of Overactive Bladder Pathophysiology: On the Way to Tailored Treatment.
    Peyronnet B; Mironska E; Chapple C; Cardozo L; Oelke M; Dmochowski R; Amarenco G; Gamé X; Kirby R; Van Der Aa F; Cornu JN
    Eur Urol; 2019 Jun; 75(6):988-1000. PubMed ID: 30922690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-3 adrenergic receptors could be significant factors for overactive bladder-related symptoms.
    Yamamichi F; Shigemura K; Behnsawy HM; Yamashita M; Shirakawa T; Fujisawa M
    Int J Clin Exp Pathol; 2015; 8(9):11863-70. PubMed ID: 26617941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Augmented bladder urothelial polyamine signaling and block of BK channel in the pathophysiology of overactive bladder syndrome.
    Li M; Sun Y; Simard JM; Wang JY; Chai TC
    Am J Physiol Cell Physiol; 2009 Dec; 297(6):C1445-51. PubMed ID: 19812367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary nerve growth factor is a better biomarker than detrusor wall thickness for the assessment of overactive bladder with incontinence.
    Kuo HC; Liu HT; Chancellor MB
    Neurourol Urodyn; 2010 Mar; 29(3):482-7. PubMed ID: 19367641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural history of non-neurogenic overactive bladder and urinary incontinence over 5 years in community-dwelling older men: The concord health and aging in men project.
    Noguchi N; Chan L; Cumming RG; Blyth FM; Handelsman DJ; Waite LM; Le Couteur DG; Naganathan V
    Neurourol Urodyn; 2017 Feb; 36(2):443-448. PubMed ID: 26756291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased serum nerve growth factor levels in patients with overactive bladder syndrome refractory to antimuscarinic therapy.
    Liu HT; Lin H; Kuo HC
    Neurourol Urodyn; 2011 Nov; 30(8):1525-9. PubMed ID: 21826717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The forefront for novel therapeutic agents based on the pathophysiology of lower urinary tract dysfunction: pathophysiology and pharmacotherapy of overactive bladder.
    Yoshida M; Masunaga K; Nagata T; Yono M; Homma Y
    J Pharmacol Sci; 2010; 112(2):128-34. PubMed ID: 20134115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.